Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
Alyssum Therapeutics

Alyssum Therapeutics

Alyssum Therapeutics is a biotechnology company that focuses on developing next-generation immunotherapies to modulate B cells.

OverviewStructured DataIssuesContributorsActivity
Is a
Organization
Organization
Company
Company
B2X
B2B
B2B
CEO
‌
Richard Fahrner
Crunchbase URL
crunchbase.com/organiz...apeutics
CTO
‌
Richard Fahrner
Industry
Biotechnology
Biotechnology
Pharmaceutical industry
Pharmaceutical industry
Instagram URL
instagram.com/squarespace
Investors
Patrick Soon-Shiong
Patrick Soon-Shiong
Navam Capital
Navam Capital
Accel
Accel
Latest Funding Round Date
October 23, 2024
Latest Funding Round Amount (USD)
26,000,000
Latest Funding Type
Series A
Series A
LinkedIn URL
@company/alyssum-therapeutics
Location
Cambridge, Massachusetts
Cambridge, Massachusetts
Number of Employees (Ranges)
1 – 10
Total Funding Amount (USD)
26,000,000
Twitter URL
@squarespace
Official Website
alyssumtx.com

Find more companies like Alyssum Therapeutics

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo